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ABSTRACT 
Objectives: Since the metabolism of the organochlorine pesticide 
dichlorodiphenyltrichloroethane (DDT) is not fully known in humans, we evaluated if 
circulating levels of a major breakdown product of DDT, p,p’-DDE,  were related to genome-
wide genetic and methylation variation in a population-based sample. 
Methods:  In the population-based Prospective Investigation of the Vasculature in Uppsala 
Seniors (PIVUS) study (1016 subjects all aged 70), circulating levels of p,p’-DDE were 
analyzed by high-resolution chromatography coupled to high-resolution mass spectrometry 
(HRGC/ HRMS). Genetic variants were genotyped and imputed (1000 Genomes reference, 
March 2012 release). Methylation sites were assayed using the Illumina 
HumanMethylation450 array in whole blood. A genome-wide association study (GWAS) 
approach was applied. 
Results:  Evidence for genome-wide significant association with p,p’-DDE levels was 
observed only for a locus at chromosome 19 corresponding to the CYP2B6 gene (lead SNP 
rs7260538). Subjects being homozygote for the G allele showed a median level of 472 ng/g 
lipid, while the corresponding level for those being homozygote for the T allele was 192 ng/g 
lipid (p=1.5 x10-31). An analysis conditioned on the lead SNP disclosed a distinct signal in the 
same gene (rs7255374, position chr19:41520351; p=2.2x10-8). 
A whole-genome methylation analysis showed one significant relationship vs p,p´-DDE levels 
(p= 6.2x10-9) located 7 kb downstream the CYP2B6 gene (cg27089200, position 
chr19:41531976). This CpG-site was also related to the lead SNP (p= 3.8x10-35), but mediated 
only 4% of the effect of the lead SNP on p,p’-DDE levels. 
Conclusion:  Circulating levels of p,p’-DDE were related to genetic variation in the CYP2B6 
gene in the general elderly population. DNA methylation in this gene is not closely linked to 
the p,p’-DDE levels. 
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1. INTRODUCTION 
Dichlorodiphenyltrichloroethane (DDT) is an insecticide heavily used since the second half of 
World War II. Due to reproductive problems observed in wild animals, DDT was banned in 
the 1970s and 1980s in most high-income countries. Despite its toxic properties, DDT is still 
used in many developing countries, mainly to fight malaria (Eskenazi and others 2009). A 
major metabolite of DDT is 2, 2-Bis (4-chlorophenyl)-1, 1-dichloroethene (p,p’-DDE). p,p’-
DDE is highly lipophilic and thereby accumulates in adipose tissue and has been estimated to 
have a half-life of 10-15 years. Although DDT is not used as a pesticide any longer in high-
income countries, due to its persistence in the environment and accumulation in the food 
chain in fish and meat, there is still exposure taking place. However, this exposure is not as 
high as before the ban. An accumulation occurs with ageing, so higher levels of DDT/p,p’-
DDE are seen in older subjects than in younger individuals as a result from a continuous 
cumulative exposure (Ye and others 2015). We have recently reported that high levels of p,p’-
DDE are related to prevalent obesity, diabetes and hypertension (Lee and others 2011; Lind 
and others 2014b; Ronn and others 2011). 
Several studies have shown that DDT alters the activity of many microsomal enzymes, 
including those involved in phase I and phase II metabolism of xenobiotics (Lubet and others 
1992; Madhukar and Matsumura 1979) in different species (Abernathy and others 1971; 
Bunyan and others 1972; Henneman and others 1994; Li and others 1995; Lubet and others 
1990). Pharmacodynamic studies on CYP2B induction indicated no important differences 
between the isomer p,p’-DDT and its metabolite DDE (Nims and others 1998). The effects 
consisted mainly of an induction of the CYP2B subfamily, a lesser induction on CYP3A, and 
minimal or no induction of CYP1A. On this basis, DDT has been considered a 
phenobarbiturate-type of inducer (Nims and others 1998; Okey 1972). 
Toxicokinetic studies of persistent organic pollutants, such as DDT/DDE, have mainly been 
conducted in an experimental setting (as cited above), and therefore such results have to be 
validated in humans. One way to perform such studies in humans is to relate functional 
genetic variations in genes known to be involved in the kinetics of environmental 
contaminants to levels of the contaminant of interest, like relating levels of polychlorinated 
biphenyls to single nuclear polymorphisms (SNP) in the CYP1A1 gene (Lind and others 
2014a). However, such an approach demands a detailed prior knowledge of the metabolism of 
the compound of interest. Another approach is to use a genome-wide association study 
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(GWAS), which test a great number of SNP across the genome without a prior hypothesis. 
We have previously used the GWAS approach and found that circulating levels of several of 
the PCBs were related to variation in the CYP2B6 gene (Ng and others 2015b), and whole 
blood manganese levels to be related to variation in the SLC39A8 and SLC30A10 genes,  
while mercury and cadmium levels shared associations with variation in other genes (Ng and 
others 2015a).  
The expression of a protein is not only governed by the variation in base-pairs in the genes, 
but also by epigenetic mechanisms, like methylation. For example, it has been shown that 
p,p’-DDE levels are linked to alterations in global DNA methylation (Rusiecki and others 
2008). 
Since the metabolism of DDT and p,p’-DDE has mainly been studied in the experimental 
setting, we used the GWAS approach to relate genetic variation to circulating levels of p,p’-
DDE. For this purpose, we used data from the Prospective Investigation of the Vasculature in 
Uppsala Seniors (PIVUS) study (Lind and others 2005), in which extensive genotyping has 
been performed, together with measurements of circulating p,p’-DDE levels. We also 
investigated if p,p’-DDE levels were related to differential methylation using a whole-genome 
approach.  
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2. MATERIAL AND METHODS 
2.1 Subjects 
The PIVUS study was originally designed to study markers of subclinical cardiovascular 
disease as risk factors for incident cardiovascular diseases (Lind and others 2005). Eligible 
subjects were all aged 70 and lived in the community of Uppsala, Sweden, with a total 
population of approximately 175,000 individuals . The subjects were randomly chosen from 
the register of community living kept by the City council of Uppsala. Of total of 2,027 invited 
individuals (50% being females), 1,016 subjects participated, giving a participation rate of 
50.1%. The study was approved by the Ethics Committee of the University of Uppsala and all 
the participants gave their informed consent prior to the study. 
 
All subjects were investigated in the morning after an overnight fast. No medication or 
smoking was allowed after midnight. The participants were asked to answer a questionnaire 
about their medical history, smoking habits and regular medication. Blood samples for 
determinations of p,p’-DDE levels, genotyping and DNA methylation were drawn at the same 
time in the fasting state at the age of 70 years. p,p’-DDE levels were measured in serum and 
DNA was prepared from leukocytes in whole blood specimens. 
 
2.2 p,p’-DDE  analyses 
p,p’-DDE  levels were measured in stored serum samples using a Micromass Autospec 
Ultima (Waters, Milford, MA, USA) high-resolution gas chromatography coupled to a high 
resolution mass spectrometry (HRGC/ HRMS) system based on the method by Sandau and 
colleagues (Barr and others 2003) with some modifications. A more detailed description of 
the analysis in this sample has previously been presented (Salihovic and others 2012). 
 
2.3 Genotyping and imputation 
Genotyping was performed on all participants using the Illumina Metabochip together with 
the Illumina OmniExpress chip. Samples were excluded based on call rate <95%, extreme 
heterozygosity (>3 SD from the mean), gender discordance, duplicated samples, close 
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relatives or ethnic outliers. Variants with exact Hardy-Weinberg equilibrium (HWE) p-
value<1×10-6, call rate<0.99, SNPs with minor allele frequency [MAF]<5% were excluded 
from the scaffold prior to imputation. The cleaned genotype data were imputed up to the 1000 
Genomes, March 2012 release reference panel (multi-ethnic panel on NCBI build 37 [b37]) 
using IMPUTE v.2.2.2. 
 
2.4 Regional DNA methylation 
Methylation sites across the genome were assayed using the Illumina HumanMethylation450k 
Beadchip, which detects methylation based on genotyping of bisulfite-converted genomic 
DNA, covering 482,421 CpG-sites and 3,091 non-CpG sites. Samples were excluded based 
on call rate (98.5% probes with detection p-value<0.01), leukocyte count >10 (×109 cells/L), 
bisulfite conversion efficiency outliers, or more than one mismatch when comparing the SNPs 
on the methylation chip and the Omni/Metabochip genotyping chips. Data on the X and Y 
chromosomes were not used in the analysis. A quantile normalization of the signal intensities 
was performed per individual and undertaken separately for type-I and type-II probes of the 
chip. Beta-values were then calculated as the percentage methylation at a site, denoted degree 
of methylation in the text. A total of 20,522 methylation sites were excluded from the analysis 
since their probes mapped to multiple locations in the genome with at least two mismatches, 
in accordance with methods used by other investigators (Grundberg and others 2013). 
 
2.5 Statistical analyses 
Since not normally distributed, p,p’-DDE was natural log-transformed before analysis, and 
used in the further analysis as a continuous variable. Since no priori hypotheses regarding 
which genes that could be related to p,p’-DDE levels were given in the present study, a 
GWAS with p,p’-DDE as dependent variable was performed using the score-based test in 
SNPTEST 2.4.1 (Marchini and others 2007), accounting for imputation uncertainty in a 
missing data likelihood and assuming an additive genetic effect. Only SNPs with MAF >0.05 
and IMPUTE2 info >0.4 were included in the analysis. Gender and two principal components 
(based on the genetic structure in the sample, here used to adjust for any genetic heterogeneity 
within the sample) were included as covariates and a p-value <5×10-8 defined a genome-wide 
significant finding.  
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The genomic inflation factor lambda (Devlin and Roeder 1999) was calculated as a quality 
control to assess the evidence for residual population structure that was not accounted for in 
the association analysis. Even studies with relatively homogeneous populations are 
susceptible to residual confounding by population stratification 
The associations between SNPs within and around CYP2B6 (10kb up and downstream of the 
transcript boundaries on b37 obtained by the UCSC Table Browser 
[http://genome.ucsc.edu/cgi-bin/hgTables]) were visualized using the program LocusZoom 
1.1 (Pruim and others 2010). Following identification of the most significantly associated 
SNP in the analysis, a conditional analysis was performed (including genotypes at this lead 
SNP with an additive genetic effect in the regression model) to identify additional distinct 
signals within or around CYP2B6. The “beta” referred to in the following text and tables is the 
regression coefficient in linear regression analysis. Thus, a beta for a SNP as an independent 
variable is the contribution of an additional allele. 
Linear regression was used to analyze the relationships between the degree of methylation at 
sites across the genome and p,p’-DDE levels, adjusting for gender, leukocyte cell fractions 
according to Houseman (Houseman and others 2012) sample batch, bisulfite conversion 
efficiency, storage time and smoking status (never, previous, current). Probes with a SNP 
within 10 bp were filtered out as were probes with known genomic variants with a minor 
allele frequency of > 1% according to the HumanMethylation450 annotation files. A 
Bonferroni-adjustment was used accounting for 322,756 tested methylation sites (critical p-
value 1.55×10-7). A interaction term (multiplicative) between the lead metahylation site and 
sex regarding p,p-DDE levels were used to evaluate any sex-differences in the lead 
metahylation site vs p,p-DDE levels relationship. 
The GWAS and whole-genome methylation analysis were performed as two separate 
analyses. 
The relations between the 2,046 SNPs within +/-0.5Mb (predictors) and the lead methylation 
site were also analyzed by linear regression analysis (p-value 2×10-5), including confounders 
stated above. In studies using both SNPs and methylation it is possible test the causal 
pathway: SNP-> methylation-> outcome to see if the association between a SNP and an 
outcome (like p,p’-DDE) is mediated by the methylation. Structural equation modeling (SEM) 
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(Westland 2015) was used to evaluate the degree of mediation of the lead methylation site on 
the relationship between the lead SNP and p,p’-DDE levels. Model used: (lead SNP-> p,p’-
DDE levels) (lead SNP->lead methylation site) (lead methylation site-> p,p’-DDE levels), 
where arrows indicate linear regression. 
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3. RESULTS 
 
Basic characteristics regarding diseases and medications are given in table 1. 
 
3.1 p,p’-DDE levels and SNPs in the CYP2B6 gene 
In the GWAS, we did not observe any evidence of systematic inflation of p-values reflecting 
residual population structure (Figure 1, lower panel; lambda, 1.01). Evidence for genome-
wide significant association with p,p’-DDE levels was observed only for one locus at 
chromosome 19 corresponding to the CYP2B6 gene (Figure 1, upper panel). 
A regional plot of the 769 SNPs within or close to CYP2B6 gene (chr 19, position range 41.4-
41.6Mb) is presented in Figure 2. The lead SNP, rs7260538 at position chr19:41514040, 
19q13.2, is located in the intron region of NM_000767.4 (minor allele frequency 0.44, Hardy-
Weinberg equilibrium 0.89, p= 1.5 x10-31). As could be seen in figure 3, subjects being 
homozygote for the G allele showed a median level of 472 ng/g lipid, while the corresponding 
level for those being homozygote for the T allele was 192 ng/g lipid (p= 1.5 x10-31). Adjusting 
for BMI did only alter this relationship to a very minor degree and the data given above is 
without BMI-adjustment. 
An analysis conditioned on the lead SNP disclosed a distinct signal (rs7255374, position 
chr19:41520351) being associated with p,p´-DDE  (p=2.2x10-8; Supplementary Figure 1, 
upper panel). This secondary signal is also located in the intron region of NM_000767.4. No 
further significant signals were found in an analysis conditioned on both of these signals (see 
Supplementary Figure 1, lower panel). If both the lead SNP and this secondary signal entered 
a regression model as independent variables and p,p-DDE as dependent variable, these two 
SNPs explained 17 % of the variation in p,p’-DDE levels in PIVUS, as determined from the 
R2-value given in the regression model (data not shown in tables).  
In suppl table 1, all association with p<5*10-8) are shown. 
CYP2B6 has 28 known alleles (http://www.cypalleles.ki.se/cyp2b6.htm). The most common 
of the haplotypes is CYP2B6*6 (frequency 0.038 in the present sample). This haplotype, 
defined by two SNPs (rs3745274, Chr19:41512841 and rs2279343, chr19:41515263), was 
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related to p,p’-DDE levels in our sample (p=0.00046). However, in an analysis conditioned 
on the two SNPs defining the CYP2B6*6 haplotype, several of the other SNPs in the CYP2B6 
region were still significantly related to p,p’-DDE levels (p<10-10 for the most strongly 
associated variant , Supplementary Figure 2). 
 
3.2 p,p’-DDE levels and methylation in the CYP2B6 gene 
A whole-genome methylation analysis suggested an association between one loci at 
chromosome 19 and p,p-DDE levels (beta 0.12, SE 0.021, p= 6.2*10-9, figure 4). According 
to that regression model, a change in 400 ng/g lipids in p,p-DDE (the interquartile range) 
corresponds to a change in methylation at that loci by 0.0091. Adding BMI as a confounder to 
the model did only change the result marginally.  
In suppl table 2, all association with a p-value < 10-5 are shown, including regression 
coefficients (beta) and SE.  
This lead methylation site being located approximately 7 kb downstream the CYP2B6 gene 
(cg27089200, position chr19:41531976, mean value 0.25 (SD 0.07)) was also related several 
SNPs in this region (most significant SNP in this analysis was rs7255904, beta 0.50, SE 
0.020, p=1.3x10-101). This methylation site was associated with the lead SNP (rs7260538) 
(beta -0.32, SE 0.025, p= 3.8x10-35, suppl figure 3). 
When the relationship between the lead methylation site and p,p’-DDE levels was conditioned 
on the lead SNP, the lead methylation site was no longer significant (p=0.25). A mediation 
analysis (SEM) showed that the lead methylation site only mediated 4% of the effect of the 
lead SNP on p,p’-DDE levels. 
We investigated if any of the drug classes given in table 1 could confound the relationships 
between p,p’-DDE levels and the lead SNP or the lead methylation site by including the 14 
kinds of drugs in one regression model with the lead SNP and one model with the lead 
methylation site. However, adjustment for the 14 drugs did not substantially alter the 
relationships between SNP/methylation sites and p,p’-DDE levels described above. 
When including an interaction term between p,p-DDE levels (continuous) and sex in the 
regression model relating p,p’-DDE levels vs. the lead methylation site, no significant 
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interaction was seen  (p=0.55). Therefore the regression coefficient (beta) was similar in men 
and women (0.15 in men and 0.11 in women). 
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Figure 1. Manhattan plot for a genome wide association study (GWAS) for plasma p,p’-DDE 
levels (upper panel) with -10log p-value at the y-axis and the gross position in the genome at 
the x-axis. A Manhattan plot shows a point for each single nucleotide polymorphism (SNP) 
that has been tested in a unique linear regression model vs. p,p’-DDE levels. The red line 
indicates the GWAS level of significance (p<5*10-8).  
The lower panel shows the corresponding Q-Q plot with the observed p-values (on a -10log 
scale) from all the linear regression models using all the available SNPs plotted vs. the 
expected p-values (given from a simulation of > 1 million regression models). The red line 
denotes the line of identity. 
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Figure 2. Regional plot for linear regression analysis regarding associations between p,p’-
DDE levels and single nucleotide polymorphisms (SNPs) in or close to the CYP2B6 gene. The 
-10log p-values for the associations are given at the y-axis and the positions at chromosome 
19 are given at the x-axis. This figure is in fact only a zoom-in of the region of interest on 
chromosome 19 that is given in the Manhattan plot in figure 1.The lead SNP is indicated by 
the grey diamond and the color of the other SNPs denotes the linkage disequilibrium (r2) 
(meaning the relationship between the different SNPs in the region) in relation to the top hit.  
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Figure 3. Box plot showing p,p-DDE levels for the different genotypes of rs7260538 at 
chromosome 19. Values >2,000 are not shown. 
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Figure 4. Manhattan plot for a whole-genome methylation analysis of plasma p,p’-DDE 
levels in relation to ~450k methylation sites (upper panel) with -10log p-value at the y-axis 
and the gross position in the genome at the x-axis. The lower panel shows a regional plot for 
linear regression analysis regarding associations between p,p’-DDE levels and methylation 
loci in or close to the CYP2B6 gene. The -10log p-values for the associations are given at the 
y-axis and the positions at chromosome 19 are given at the x-axis. The lead methylation site 
in this analysis showed a p-value of 6.2*10-9. 
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4. DISCUSSION 
The present study showed that circulating levels of p,p’-DDE, a more stable metabolite of 
DDT, were related to genetic variation in the CYP2B6 gene. This finding is in accordance 
with experimental studies showing that DDT and its metabolite p,p’-DDE cause induction of 
CYP2B enzymes (Nims and others 1998; Okey 1972), but this is the first study to show this 
link between p,p’-DDE and CYP2B6 in humans. We found DNA methylation in this gene to 
not play a major role for the p,p’-DDE levels, since the impact of DNA methylation was 
minor when taken the lead SNP into account in the SEM analyses. 
p,p’-DDE is still measurable in the circulation in almost all individuals in high-income 
countries (Salihovic and others 2012). The median concentration of p,p’-DDE in this study of 
elderly individuals is similar to those previously reported from Sweden and Norway (Hagmar 
and others 2006; Hardell and others 2010; Sandanger and others 2006). However, the levels 
of p,p’-DDE in the present study were about three times lower when comparing with elderly 
individuals from Belgium (Koppen and others 2002) and the United States (NHANES 2003-
2004) in samples collected during the same time period. 
The CYP2B6 expression and activity is highly variable between individuals, owing to genetic 
polymorphisms. Regarding CYP2B6, interindividual variability exist at both mRNA and 
protein levels, and these differences are roughly over 100-fold (Wang and Tompkins 2008). 
Several functionally relevant single-nucleotide polymorphisms (SNPs) were reported to affect 
CYP2B6 activity. Their most common functionally deficient allele is CYP2B6*6. The 
CYP2B6*6 homozygous carriers CYP2B6*6/*6, and its compound heterozygous genotypes 
CYP2B6*1/*6 were found to show poor metabolizer phenotypes for several drugs in vivo 
(Lang and others 2001). It can therefore be assumed that SNPs in this gene could identify 
those with a poor metabolizing capacity of p,p’-DDE as well. 
From the conditional analysis it is evident that there are at least two distinct association 
signals in the CYP2B6 region related to p,p’-DDE levels. Since both of these SNPs are located 
in an intronic region, it is far from clear how these SNP might influence the p,p´-DDE levels, 
but together they explained 17% of the variation in p,p’-DDE levels in PIVUS, showing that 
CYP2B6 activity is of importance for the circulating levels of this organochlorine pesticide. 
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In contrast to the top hits in the CYP2B6 region described here, it is known that the common 
CYP2B6*6 haplotype, encoding a change from glutamine to histidine in one amino acid 
position of the protein, could govern CYP2B6 activity in vitro. Also, the CYP2B6*6 
haplotype was related to the p,p’-DDE levels, but when a further analysis was conducted 
conditioned on the SNPs in the CYP2B6*6 haplotype, a great number of other SNPs in the 
region were also significantly related to p,p´-DDE levels, suggesting that there is additional 
genetic variation of importance for p,p’-DDE levels in this region, beyond the known 
CYP2B6*6 haplotype. It should be noted that the frequency of the CYP2B6*6 haplotype was 
low, so the power to detect an independent contribution of this haplotype is limited. 
The CYP2B6 enzyme is mainly expressed in the liver and in the brain in humans (Lamba and 
others 2003) The expression of this enzyme in the liver is very important, since it has been 
estimated that CYP2B6 metabolizes about 25% of all pharmaceutical drugs on the market, 
and the expression is subject to a high degree of variability due to variation in the gene (Yang 
and others 2013) Since DDT and p,p’-DDE are highly lipophilic they do accumulate in liver 
tissue and previously experimental studies and the present study show that variation in 
CYP2B6 is of major importance for the clearance of DDT/ p,p’-DDE from the body in 
humans. 
In addition to analyzing the relationships between p,p’-DDE levels and genetic variation in 
the CYP2B6 gene, we also investigated how p,p’-DDE levels were associated with the degree 
of methylation in CpG-sites across the genome, since methylation could affect the activity of 
the enzyme. We found that the degree of methylation in one locus, 7 kb downstream of the 
CYP2B6 gene. was related to p,p’-DDE levels. This lead CpG-site was related to the lead SNP 
(and to other SNPs in that region), but since a further analysis showed that only 4% of the 
total effect of the lead SNP on p,p’-DDE levels was mediated by the lead methylation site, 
this effect seems to be of minor importance. 
If an association between p,p’-DDE levels and a methylation site within or close to a gene is 
seen, as in the present study, two possible explanations exit. First, an SNP within or close to 
the gene governs the degree of methylation at that particular site and this SNP is also related 
to p,p’-DDE levels. In that case, the degree of methylation is a mediator of the effect of the 
SNP on p,p’-DDE levels. This can be tested by SEM analysis as performed in the present 
study.  
Second, the methylation site is not related to the SNPs in that region, and therefore the effect 
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of the methylation site on p,p’-DDE levels is independent of SNPs. In the present case, the 
lead methylation site was related to several SNPs in the region, including the lead SNP, and 
therefore the performed SEM analysis could conclude that the degree of methylation was of 
minor importance as compared to the effect of the SNP. 
In the present study, it was disclosed that the association between the p,p’-DDE levels and the 
lead methylation site was in fact governed by a SNP. This finding is intriguing but it needs 
replication and corroboration by other studies in which genetic and epigenetic data are 
available 
 
Just as in our previous study on genetic variation and PCB levels (Ng and others 2015b), we 
now found that the lead SNP is intronic. How intronic variation influence protein levels and 
function is not fully understood but several mechanisms are likely to exist. First, an intronic 
variant might be in linkage with a function SNP not measured or imputed. Second, genetic 
and epigenetic variants in introns can influence expression of different gene isoforms or 
alternative splicing. Third, alternative promoters for transcription of gene variants could be 
influenced by intronic variation. 
The major strength of the present study is the large sample with both p,p’-DDE 
measurements, and extensive genotyping and methylation data. The limitations include that 
our study is conducted in elderly Caucasians, which limits the generalizability to other age- 
and ethnic groups, and the fact that we cannot replicate our findings in an independent 
sample, since we are not aware of other samples with both p,p’-DDE measurements and 
genetic information. 
A power analysis taken place before this study was conducted showed that with 
approximately 1,000 individuals in the study, we have a limited power to detect relationships 
where an exposure will explain less than 4% of the outcome. Thus, it is not excluded that less 
powerful associations between p,p’-DDE and variation in other genes than CYP2B6 do exist. 
The PIVUS study had a moderate participation rate of 50%. We have made a analysis of the 
non-participants and found a slightly higher prevalence of disabling disorders, such as stroke, 
but the prevalence’s of many other diseases, like hypertension and myocardial infarction were 
similar in participants and non-participants (for details, see Lind et al 2005) (Lind and others 
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2005). It is a well-known experience in population-based epidemiology that non-participants 
are somewhat more sick the participants. Since the aim of the present study was to investigate 
links between p,p’-DDE levels and genetics it will not be a disadvantage with a healthier 
sample than the underlying population, since diseases tend to obscure basic mechanisms of 
toxicokinetics. 
It should also be acknowledged that a cross-sectional study has limitations regarding 
mediation analysis. Here we postulated that genetic variation->methylation changes-> altered 
p,p-DDE levels. Given the cross sectional nature other alternative pathways might exists, like 
p,p-DDE -> altered methylation. Only longitudinal studies could solve those issues. Another 
limitation is that the results from the whole genome methylation assay was not validated by 
another type of assay. 
 
In conclusion, genetic variation in the CYP2B6 gene was related to circulating p,p´-DDE 
levels in the general elderly population. DNA methylation in this gene does not seem to play a 
major importance for the p,p’-DDE levels, but the fact that both an untargeted genome-wide 
genomic study and a methylation study linked p,p-DDE levels to the CYP2B6 make it likely 
that CYP2B6 plays a major role in the metabolism of DDT in humans. 
 
6. ACKNOWLEDGEMENTS  
This study was supported by the Swedish Research Council for Environment, Agricultural 
Sciences and Spatial Planning (www.formas.se).  
This study could not have been conducted without the contribution from participants, 
researchers and others engaged in the PIVUS study.  
Andrew P Morris is a Wellcome Trust Senior Fellow in Basic Biomedical Science, under 
award WT098017 
  
	   23	  
REFERENCES 
Abernathy,	  C.O.;	  Hodgson,	  E.;	  Guthrie,	  F.E.	  Structure-­‐activity	  relationships	  on	  the	  induction	  of	  hepatic	  
microsomal	  enzymes	  in	  the	  mouse	  by	  1,1,1-­‐trichloro-­‐2,2-­‐bis(p-­‐chlorophenyl)	  ethane(DDT)	  
analogs.	  Biochem	  Pharmacol.	  20:2385-­‐2393;	  1971	  
Barr,	  J.R.;	  Maggio,	  V.L.;	  Barr,	  D.B.;	  Turner,	  W.E.;	  Sjodin,	  A.;	  Sandau,	  C.D.;	  Pirkle,	  J.L.;	  Needham,	  L.L.;	  
Patterson,	  D.G.,	  Jr.	  New	  high-­‐resolution	  mass	  spectrometric	  approach	  for	  the	  measurement	  
of	  polychlorinated	  biphenyls	  and	  organochlorine	  pesticides	  in	  human	  serum.	  J	  Chromatogr	  B	  
Analyt	  Technol	  Biomed	  Life	  Sci.	  794:137-­‐148;	  2003	  
Bunyan,	  P.J.;	  Townsend,	  M.G.;	  Taylor,	  A.	  Pesticide-­‐induced	  changes	  in	  hepatic	  microsomal	  enzyme	  
systems.	  Some	  effects	  of	  1,1-­‐DI(p-­‐chlorophenyl)-­‐2,2,2-­‐trichloroethane	  (DDT)	  and	  1,1-­‐DI(p-­‐
chlorophenyl)-­‐2,2-­‐dichloroethylene	  (DDE)	  in	  the	  rat	  and	  Japanese	  quail.	  Chem	  Biol	  Interact.	  
5:13-­‐26;	  1972	  
Devlin,	  B.;	  Roeder,	  K.	  Genomic	  control	  for	  association	  studies.	  Biometrics.	  55:997-­‐1004;	  1999	  
Eskenazi,	  B.;	  Chevrier,	  J.;	  Rosas,	  L.G.;	  Anderson,	  H.A.;	  Bornman,	  M.S.;	  Bouwman,	  H.;	  Chen,	  A.;	  Cohn,	  
B.A.;	  de	  Jager,	  C.;	  Henshel,	  D.S.;	  Leipzig,	  F.;	  Leipzig,	  J.S.;	  Lorenz,	  E.C.;	  Snedeker,	  S.M.;	  
Stapleton,	  D.	  The	  Pine	  River	  statement:	  human	  health	  consequences	  of	  DDT	  use.	  Environ	  
Health	  Perspect.	  117:1359-­‐1367;	  2009	  
Grundberg,	  E.;	  Meduri,	  E.;	  Sandling,	  J.K.;	  Hedman,	  A.K.;	  Keildson,	  S.;	  Buil,	  A.;	  Busche,	  S.;	  Yuan,	  W.;	  
Nisbet,	  J.;	  Sekowska,	  M.;	  Wilk,	  A.;	  Barrett,	  A.;	  Small,	  K.S.;	  Ge,	  B.;	  Caron,	  M.;	  Shin,	  S.Y.;	  
Multiple	  Tissue	  Human	  Expression	  Resource,	  C.;	  Lathrop,	  M.;	  Dermitzakis,	  E.T.;	  McCarthy,	  
M.I.;	  Spector,	  T.D.;	  Bell,	  J.T.;	  Deloukas,	  P.	  Global	  analysis	  of	  DNA	  methylation	  variation	  in	  
adipose	  tissue	  from	  twins	  reveals	  links	  to	  disease-­‐associated	  variants	  in	  distal	  regulatory	  
elements.	  Am	  J	  Hum	  Genet.	  93:876-­‐890;	  2013	  
Hagmar,	  L.;	  Wallin,	  E.;	  Vessby,	  B.;	  Jonsson,	  B.A.;	  Bergman,	  A.;	  Rylander,	  L.	  Intra-­‐individual	  variations	  
and	  time	  trends	  1991-­‐2001	  in	  human	  serum	  levels	  of	  PCB,	  DDE	  and	  hexachlorobenzene.	  
Chemosphere.	  64:1507-­‐1513;	  2006	  
Hardell,	  E.;	  Carlberg,	  M.;	  Nordstrom,	  M.;	  van	  Bavel,	  B.	  Time	  trends	  of	  persistent	  organic	  pollutants	  in	  
Sweden	  during	  1993-­‐2007	  and	  relation	  to	  age,	  gender,	  body	  mass	  index,	  breast-­‐feeding	  and	  
parity.	  Sci	  Total	  Environ.	  408:4412-­‐4419;	  2010	  
Henneman,	  J.R.;	  Fox,	  S.D.;	  Lubet,	  R.A.;	  Ward,	  J.M.;	  Nims,	  R.W.	  Induction	  of	  cytochrome	  P-­‐450	  in	  
Sigmodon	  hispidus	  (cotton	  rats)	  exposed	  to	  dietary	  Aroclor	  1254.	  J	  Toxicol	  Environ	  Health.	  
41:369-­‐386;	  1994	  
Houseman,	  E.A.;	  Accomando,	  W.P.;	  Koestler,	  D.C.;	  Christensen,	  B.C.;	  Marsit,	  C.J.;	  Nelson,	  H.H.;	  
Wiencke,	  J.K.;	  Kelsey,	  K.T.	  DNA	  methylation	  arrays	  as	  surrogate	  measures	  of	  cell	  mixture	  
distribution.	  BMC	  Bioinformatics.	  13:86;	  2012	  
Koppen,	  G.;	  Covaci,	  A.;	  Van	  Cleuvenbergen,	  R.;	  Schepens,	  P.;	  Winneke,	  G.;	  Nelen,	  V.;	  van	  Larebeke,	  
N.;	  Vlietinck,	  R.;	  Schoeters,	  G.	  Persistent	  organochlorine	  pollutants	  in	  human	  serum	  of	  50-­‐65	  
years	  old	  women	  in	  the	  Flanders	  Environmental	  and	  Health	  Study	  (FLEHS).	  Part	  1:	  
Concentrations	  and	  regional	  differences.	  Chemosphere.	  48:811-­‐825;	  2002	  
Lamba,	  V.;	  Lamba,	  J.;	  Yasuda,	  K.;	  Strom,	  S.;	  Davila,	  J.;	  Hancock,	  M.L.;	  Fackenthal,	  J.D.;	  Rogan,	  P.K.;	  
Ring,	  B.;	  Wrighton,	  S.A.;	  Schuetz,	  E.G.	  Hepatic	  CYP2B6	  expression:	  gender	  and	  ethnic	  
differences	  and	  relationship	  to	  CYP2B6	  genotype	  and	  CAR	  (constitutive	  androstane	  receptor)	  
expression.	  J	  Pharmacol	  Exp	  Ther.	  307:906-­‐922;	  2003	  
Lang,	  T.;	  Klein,	  K.;	  Fischer,	  J.;	  Nussler,	  A.K.;	  Neuhaus,	  P.;	  Hofmann,	  U.;	  Eichelbaum,	  M.;	  Schwab,	  M.;	  
Zanger,	  U.M.	  Extensive	  genetic	  polymorphism	  in	  the	  human	  CYP2B6	  gene	  with	  impact	  on	  
expression	  and	  function	  in	  human	  liver.	  Pharmacogenetics.	  11:399-­‐415;	  2001	  
Lee,	  D.H.;	  Lind,	  P.M.;	  Jacobs,	  D.R.;	  Salihovic,	  S.;	  van	  Bavel,	  B.;	  Lind,	  L.	  Polychlorinated	  Biphenyls	  and	  
Organochlorine	  Pesticides	  in	  Plasma	  Predict	  Development	  of	  Type	  2	  Diabetes	  in	  the	  Elderly.	  
Diabetes	  Care.	  34:1778-­‐1784;	  2011	  
	   24	  
Li,	  H.C.;	  Dehal,	  S.S.;	  Kupfer,	  D.	  Induction	  of	  the	  hepatic	  CYP2B	  and	  CYP3A	  enzymes	  by	  the	  
proestrogenic	  pesticide	  methoxychlor	  and	  by	  DDT	  in	  the	  rat.	  Effects	  on	  methoxychlor	  
metabolism.	  J	  Biochem	  Toxicol.	  10:51-­‐61;	  1995	  
Lind,	  L.;	  Fors,	  N.;	  Hall,	  J.;	  Marttala,	  K.;	  Stenborg,	  A.	  A	  comparison	  of	  three	  different	  methods	  to	  
evaluate	  endothelium-­‐dependent	  vasodilation	  in	  the	  elderly:	  the	  Prospective	  Investigation	  of	  
the	  Vasculature	  in	  Uppsala	  Seniors	  (PIVUS)	  study.	  Arterioscler	  Thromb	  Vasc	  Biol.	  25:2368-­‐
2375;	  2005	  
Lind,	  L.;	  Penell,	  J.;	  Syvanen,	  A.C.;	  Axelsson,	  T.;	  Ingelsson,	  E.;	  Morris,	  A.P.;	  Lindgren,	  C.;	  Salihovic,	  S.;	  
van	  Bavel,	  B.;	  Lind,	  P.M.	  Genetic	  variation	  in	  the	  CYP1A1	  gene	  is	  related	  to	  circulating	  PCB118	  
levels	  in	  a	  population-­‐based	  sample.	  Environ	  Res.	  133:135-­‐140;	  2014a	  
Lind,	  P.M.;	  Penell,	  J.;	  Salihovic,	  S.;	  van	  Bavel,	  B.;	  Lind,	  L.	  Circulating	  levels	  of	  p,p	  '-­‐DDE	  are	  related	  to	  
prevalent	  hypertension	  in	  the	  elderly.	  Environmental	  Research.	  129:27-­‐31;	  2014b	  
Lubet,	  R.A.;	  Dragnev,	  K.H.;	  Chauhan,	  D.P.;	  Nims,	  R.W.;	  Diwan,	  B.A.;	  Ward,	  J.M.;	  Jones,	  C.R.;	  Rice,	  J.M.;	  
Miller,	  M.S.	  A	  pleiotropic	  response	  to	  phenobarbital-­‐type	  enzyme	  inducers	  in	  the	  F344/NCr	  
rat.	  Effects	  of	  chemicals	  of	  varied	  structure.	  Biochem	  Pharmacol.	  43:1067-­‐1078;	  1992	  
Lubet,	  R.A.;	  Guengerich,	  F.P.;	  Nims,	  R.W.	  The	  induction	  of	  alkoxyresorufin	  metabolism:	  a	  potential	  
indicator	  of	  environmental	  contamination.	  Arch	  Environ	  Contam	  Toxicol.	  19:157-­‐163;	  1990	  
Madhukar,	  B.V.;	  Matsumura,	  F.	  Comparison	  of	  induction	  patterns	  of	  rat	  hepatic	  microsomal	  mixed-­‐
function	  oxidases	  by	  pesticides	  and	  related	  chemicals.	  Pesticide	  Biochemistry	  and	  Physiology.	  
11:301-­‐308;	  1979	  
Marchini,	  J.;	  Howie,	  B.;	  Myers,	  S.;	  McVean,	  G.;	  Donnelly,	  P.	  A	  new	  multipoint	  method	  for	  genome-­‐
wide	  association	  studies	  by	  imputation	  of	  genotypes.	  Nat	  Genet.	  39:906-­‐913;	  2007	  
Ng,	  E.;	  Lind,	  P.M.;	  Lindgren,	  C.;	  Ingelsson,	  E.;	  Mahajan,	  A.;	  Morris,	  A.;	  Lind,	  L.	  Genome-­‐wide	  
association	  study	  of	  toxic	  metals	  and	  trace	  elements	  reveals	  novel	  associations.	  Hum	  Mol	  
Genet.	  24:4739-­‐4745;	  2015a	  
Ng,	  E.;	  Salihovic,	  S.;	  Lind,	  P.M.;	  Mahajan,	  A.;	  Syvanen,	  A.C.;	  Axelsson,	  T.;	  Ingelsson,	  E.;	  Lindgren,	  C.M.;	  
van	  Bavel,	  B.;	  Morris,	  A.P.;	  Lind,	  L.	  Genome-­‐wide	  association	  study	  of	  plasma	  levels	  of	  
polychlorinated	  biphenyls	  disclose	  an	  association	  with	  the	  CYP2B6	  gene	  in	  a	  population-­‐
based	  sample.	  Environ	  Res.	  140:95-­‐101;	  2015b	  
Nims,	  R.W.;	  Lubet,	  R.A.;	  Fox,	  S.D.;	  Jones,	  C.R.;	  Thomas,	  P.E.;	  Reddy,	  A.B.;	  Kocarek,	  T.A.	  Comparative	  
pharmacodynamics	  of	  CYP2B	  induction	  by	  DDT,	  DDE,	  and	  DDD	  in	  male	  rat	  liver	  and	  cultured	  
rat	  hepatocytes.	  J	  Toxicol	  Environ	  Health	  A.	  53:455-­‐477;	  1998	  
Okey,	  A.B.	  Dimethylbenzanthracene-­‐Induced	  Mammary	  Tumors	  in	  Rats	  -­‐	  Inhibition	  by	  Ddt.	  Life	  Sci.	  
11:833-­‐&;	  1972	  
Pruim,	  R.J.;	  Welch,	  R.P.;	  Sanna,	  S.;	  Teslovich,	  T.M.;	  Chines,	  P.S.;	  Gliedt,	  T.P.;	  Boehnke,	  M.;	  Abecasis,	  
G.R.;	  Willer,	  C.J.	  LocusZoom:	  regional	  visualization	  of	  genome-­‐wide	  association	  scan	  results.	  
Bioinformatics.	  26:2336-­‐2337;	  2010	  
Ronn,	  M.;	  Lind,	  L.;	  van	  Bavel,	  B.;	  Salihovic,	  S.;	  Michaelsson,	  K.;	  Lind,	  P.M.	  Circulating	  levels	  of	  
persistent	  organic	  pollutants	  associate	  in	  divergent	  ways	  to	  fat	  mass	  measured	  by	  DXA	  in	  
humans.	  Chemosphere.	  85:335-­‐343;	  2011	  
Rusiecki,	  J.A.;	  Baccarelli,	  A.;	  Bollati,	  V.;	  Tarantini,	  L.;	  Moore,	  L.E.;	  Bonefeld-­‐Jorgensen,	  E.C.	  Global	  DNA	  
hypomethylation	  is	  associated	  with	  high	  serum-­‐persistent	  organic	  pollutants	  in	  Greenlandic	  
Inuit.	  Environ	  Health	  Perspect.	  116:1547-­‐1552;	  2008	  
Salihovic,	  S.;	  Lampa,	  E.;	  Lindstrom,	  G.;	  Lind,	  L.;	  Lind,	  P.M.;	  van	  Bavel,	  B.	  Circulating	  levels	  of	  persistent	  
organic	  pollutants	  (POPs)	  among	  elderly	  men	  and	  women	  from	  Sweden:	  results	  from	  the	  
Prospective	  Investigation	  of	  the	  Vasculature	  in	  Uppsala	  Seniors	  (PIVUS).	  Environ	  Int.	  44:59-­‐
67;	  2012	  
Sandanger,	  T.M.;	  Brustad,	  M.;	  Sandau,	  C.D.;	  Lund,	  E.	  Levels	  of	  persistent	  organic	  pollutants	  (POPs)	  in	  
a	  coastal	  northern	  Norwegian	  population	  with	  high	  fish-­‐liver	  intake.	  J	  Environ	  Monit.	  8:552-­‐
557;	  2006	  
Wang,	  H.;	  Tompkins,	  L.M.	  CYP2B6:	  new	  insights	  into	  a	  historically	  overlooked	  cytochrome	  P450	  
isozyme.	  Curr	  Drug	  Metab.	  9:598-­‐610;	  2008	  
	   25	  
Westland,	  C.J.	  Structural	  Equation	  Modeling:	  From	  Paths	  to	  Networks.	  .	  Structural	  Equation	  Models:	  
Springer	  International	  Publishing;	  2015	  
Yang,	  L.;	  Price,	  E.T.;	  Chang,	  C.W.;	  Li,	  Y.;	  Huang,	  Y.;	  Guo,	  L.W.;	  Guo,	  Y.;	  Kaput,	  J.;	  Shi,	  L.;	  Ning,	  B.	  Gene	  
expression	  variability	  in	  human	  hepatic	  drug	  metabolizing	  enzymes	  and	  transporters.	  PLoS	  
One.	  8:e60368;	  2013	  
Ye,	  M.;	  Beach,	  J.;	  Martin,	  J.W.;	  Senthilselvan,	  A.	  Association	  between	  lung	  function	  in	  adults	  and	  
plasma	  DDT	  and	  DDE	  levels:	  results	  from	  the	  Canadian	  Health	  Measures	  Survey.	  Environ	  
Health	  Perspect.	  123:422-­‐427;	  2015	  
 
